Coronavirus COVID-19 FAQs
Please continue to refer to this page and the latest official advice and guidance from the Ministry of Health (MOH), Higher Education Council (HEC) and other government entities.
Anyone who experiences symptoms of the Coronavirus (COVID-19) or may have been in contact with a person who has the Coronavirus (COVID-19) is advised to contact the Hotline (444).
Yes. If you are sharing your home with others, you should stay in a different room from other people or be separated as much as possible. Wear a surgical mask when you are in the same room as another person, and when seeking medical care. Use a separate bathroom, if available.
Make sure that you do not share a room with people who are at risk of severe disease, such as elderly people and those who have heart, lung or kidney conditions, and diabetes.
Visitors who do not have an essential need to be in the home should not visit while you are isolating.
The health and safety of our students remains our priority, therefore RCSI Bahrain has invested in increasing the level of general cleaning completed on campus.
Extra measures we have put in place are as follows (this list is not inclusive):
- An Isolation Room has been designated and prepared for any person who experiences any symptoms of COVID-19 while on-campus.
- We have arranged for frequently touched surfaces, such as door handles, light switches, handrails etc. to be cleaned at increased frequency
- Welfare facilities and communal areas will also be cleaned more frequently.
- Each room, office, laboratory, tutorial room and communal area will be provided with cleaning materials to keep the environment hygienically clean and we are advised to regularly clean any personal items brought in from home.
- In addition to the scheduled cleaning and disinfection that would be carried out by the soft services team, everyone will be expected to clean their own stations daily and more importantly to “clean as you go” when moving around on campus to maintain the hygiene standards needed to kill any virus particles.
Passengers are advised to check with their airlines to confirm the status of their flights in advance.
All arriving passengers will be routed through the airport as per their travel histories, countries of travel origin and any symptoms reported.
Passengers will be taken to designated areas of the airport for applicable PCR Testing and mandatory clinical examinations, which takes a minimum of two hours after arrival.
If a COVID-19 test result is positive, passengers/citizens/residents will be advised of further courses of action by the Ministry of Health (MoH) staff. Passengers will also be followed up with by the Ministry of Health.
Starting from 7 May 2021, passengers vaccinated in Bahrain, in the GCC or in a country with mutual vaccination recognition will need to present a valid proof of vaccination upon arrival.
Starting from 25 June 2021, passengers arriving from Red List countries (India, Pakistan, Sri Lanka, Bangladesh, Nepal, and Vietnam), including passengers who have transited those countries at any point in the last 14 days, are prohibited from entry unless they are a citizen or resident of Bahrain.
Passengers eligible for entry are required to present a negative test certificate, featuring a QR code, for a PCR test administered within 48 hours of their departure. Passengers are also required to undergo testing on arrival and on the 10th day of their stay in Bahrain.
A 10-day quarantine period is mandatory for passengers arriving from a Red List country. Passengers aged 6 and below are exempt from these requirements.
All passengers who are vaccinated and are arriving from non-Red List countries must do the following:
- Have a negative test 72h prior to their flight
- Perform PCR test on arrival
- Quarantine for 10 days
- Exit test on day 10
For non-vaccinated passengers and passengers without a vaccination certificate recognised by the Government of Bahrain, a mandatory 10-day quarantine period applies. Passengers aged 6 and below are exempt from these requirements.
Under the current regulations, the following exceptions apply to qualifying passengers arriving from non-Red List countries:
- Fully vaccinated passengers with certificates issued by health authorities in the Kingdom of Bahrain, certificate issued by a country whose vaccination certificate is approved by the Ministry of Health in Bahrain, or countries with which Bahrain has signed mutual recognition agreements are excluded from:
- Pre-departure testing
- Quarantine requirements.
Passengers are nevertheless required to undergo testing on arrival and on the 10th day of their stay in Bahrain are excluded from quarantine requirements.
- United States
- United Kingdom
- European Union Countries
- New Zealand
- South Korea
Travelers from the above countries are exempt from precautionary quarantine upon arrival, as long as official vaccination certificates issued by their countries are provided. However, they must still undergo a PCR test upon arrival and on the 10th day of their stay in Bahrain (cost of BHD 24 for both).
- For the latest updates on COVID-19 in Bahrain, please visit Ministry of Health website· For more details on travel rules and procedures, please click here
- If you are unwell in Bahrain with cough, fever, difficulty breathing, please stay at home, call 444 and follow instructions provided.
- For students, please liaise with your SARA coordinator or the Student Health and Wellbeing Centre.
- For staff, please liaise with HR.
For international students, we understand these are very difficult times to be away from friends and family at home. While we acknowledge that it is each student’s personal decision as to whether or not you choose to travel overseas during the year, we would like to remind you that the university advises against all unnecessary travel.
RCSI Bahrain strongly advises our SC2 students not to travel internationally this academic year.
With the current international travel situation rapidly evolving, and ongoing requirements to restrict movement upon arrival in many home countries applying, we believe the safest thing to do in terms of protecting human health, as well as minimizing risks to your academic progression, is not to travel overseas unless absolutely necessary.
There are also cost implications to be aware of, such as flight cancellations, COVID-19 testing fees, and quarantine regulations in different countries. Please also do not endanger yourself – or your family, friends, fellow students, staff and particularly patients- who will trust you to keep your commitments to public safety.
If you do decide to travel and cannot return to Bahrain on time, we may not be able to provide you with adequate catch-up for required clinical placement and this of course will impact your ability to successfully complete the academic year 20-21. We greatly appreciate that students will have to make a difficult choice not to travel, in the interests of the wider collective public health. RCSI Bahrain will work hard to support you over this time.
This situation is evolving, and staff and students should continue to regularly check the RCSI Bahrain FAQ page along with the following online resources:
For more information on how Bahrain is battling COVID-19 please download the following documents
RCSI Bahrain Contribution to COVID-19 Clinical Trials
RCSI Bahrain has been honourably nominated to support the COVID-19 clinical trials in Bahrain under the direction of Professor Stephen Atkin, Head of School of Postgraduate Research.
With the aim to enhance the treatment protocols for COVID-19 patients in Bahrain and beyond, RCSI Bahrain sponsored the National Convalescent Plasma Clinical Trial in COVID-19 patients, in collaboration with the Bahrain Defence Force Hospital (BDF) and the Ministry of Health. This initiative comes under the directives from the Supreme Council of Health (SCH) President and taskforce head, His Excellency Lieutenant General Dr Shaikh Mohammed bin Abdulla Al Khalifa.
The clinical trial, which is being conducted in three centres around Bahrain, entails taking antibody-rich plasma that has been given by subjects that have recovered from COVID-19 and injecting it into patients who are severely suffering from the disease. Patients who have contracted COVID-19 and require oxygen therapy will be randomised to either the plasma treatment with supporting care, or normal supporting care, both of which will include drug treatment against the virus.